Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Regulated information - Transparency Statement Clay

10 May 2019

Mr Thomas M. Clay and Mrs Lavinia Clay: control and voting rights Oxurion NV

Leuven, Belgium, 10 May 2019 – Pursuant to Belgian transparency legislation (Law of 2 May 2007), Oxurion NV (Euronext Brussels: OXUR) received transparency notifications on 30 April 2019 from Mr. Thomas M. Clay and his controlled entities (Landon T. Clay 2017-1 Annuity Trust, Estate of Landon T. Clay, East Hill Hedge Fund LLC, Monadnock Charitable Lead Annuity Trust, Clay Fellowships Charitable Trust and The Clay Mathematics Institute, Inc.) and from Mrs. Lavinia D. Clay.

As of 1 May 2019, Mrs. Lavinia D. Clay, the East Hill Hedge Fund, LLC, and the Monadnock Charitable Lead Annuity Trust entered into an investment advisor agreement with Epacria Capital Partners, LLC, in which Mr Thomas M. Clay has complete authority on a discretionary base over the voting rights related to the Oxurion shares of Mrs. Lavinia D. Clay, the Monadnock Charitable Lead Annuity Trust, and the East Hill Hedge Fund, LLC.

As a result, the voting percentage of Thomas M. Clay is now 8.78%, representing 3,361,555 of the current 38,291,950 outstanding Oxurion shares.
On 2 May 2019, based on all received transparency declarations received, Oxurion NV is aware of the following participations:

Shareholder # of securities % of voting rights
Mr Thomas M. Clay and entities controlled by him 3,361,555 8.78%
Baron Philippe Vlerick and entities controlled by him 2,324,719 6.07%
Novartis Pharma AG 2,177,226 5.69%
Press release attachment: 
Tags: 
Investors; Company